老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Global X Aging Population ETF
36.93
-0.0850
-0.23%
盤後：
36.99
0.0650
+0.18%
19:56 EDT
成交量：
4,964
成交額：
18.36萬
市值：
9,119.44萬
市盈率：
- -
高：
37.08
開：
37.08
低：
36.83
收：
37.01
52周最高：
39.48
52周最低：
32.44
股本：
246.97萬
流通股本：
246.97萬
量比：
0.39
換手率：
0.20%
股息：
0.33
股息率：
0.89%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影
路透中文
·
09/07
麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航
格隆汇
·
09/07
山東省寧陽縣市場監管局開展醫療器械專項現場檢查
中国质量新闻网
·
09/07
又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？
智通财经
·
09/07
從美妝到生物科技公司 植物醫生挺進大健康領域
同花顺
·
09/07
高瓴重倉的醫療器械公司，IPO首日開盤跌超30%
直通IPO
·
09/07
海南出台醫療器械委託生產監管新政
智通财经
·
09/06
格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械
睿见Economy
·
09/05
研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方
路透中文
·
09/05
服務退役軍人有成效，貴州企業獲國家級授牌！
滚动播报
·
09/04
聯邦制藥(03933.HK)：UBT251注射液完成中國超重/肥胖III期臨床研究首例試驗參與者給藥
智通财经
·
09/04
里昂：生物科技行業基本面仍穩固，首選百濟神州、信達生物及維立志博
智通财经
·
09/04
從護膚到大健康，植物醫生想成為一家生物科技公司
蓝鲸财经
·
09/04
我國長期護理保險參保人數超3.2億
金吾财讯
·
09/04
我國長期護理保險參保人數超3.2億
智通财经
·
09/04
我國長期護理保險參保人數超3.2億
格隆汇
·
09/04
109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益
智通财经
·
09/04
109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益
智通财经
·
09/04
艾伯維公布Cervino三期試驗積極頂線結果：Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期
美股速递
·
09/03
艾伯維的血液癌症藥物達到了晚期臨床試驗的目標
路透中文
·
09/03
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/AGNG/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"AGNG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNG\",,,,,undefined,":{"symbol":"AGNG","market":"US","secType":"STK","nameCN":"Global X Aging Population ETF","latestPrice":36.925,"timestamp":1789761600000,"preClose":37.01,"halted":0,"volume":4964,"hourTrading":{"tag":"盘后","latestPrice":36.99,"preClose":36.925,"latestTime":"19:56 EDT","volume":44,"amount":1899.755,"timestamp":1789775780128,"change":0.065,"changeRate":0.00176,"amplitude":0},"delay":0,"changeRate":-0.0022966765738989692,"floatShares":2469721,"shares":2469721,"eps":0,"marketStatus":"休市中","change":-0.085,"latestTime":"09-18 16:00:00 EDT","open":37.08,"high":37.08,"low":36.8312,"amount":183635.997092,"amplitude":0.006723,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.01,"sharesOutstanding":2330000,"nav":36.91,"aum":91169422.72,"dividendRate":0.008921,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":36.99,"preClose":36.925,"latestTime":"19:56 EDT","volume":44,"amount":1899.755,"timestamp":1789775780128,"change":0.065,"changeRate":0.00176,"amplitude":0},"volumeRatio":0.3896877826895244,"impliedVol":0.378,"impliedVolPercentile":0.8327},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNG\",,,,,undefined,":{"symbol":"AGNG","floatShares":2469721,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3896877826895244,"shares":2469721,"dividePrice":0.3294,"high":37.08,"amplitude":0.006723,"preClose":37.01,"low":36.8312,"week52Low":32.4401,"pbRate":"--","week52High":39.48,"institutionHeld":0,"latestPrice":36.925,"eps":0,"divideRate":0.008921,"volume":4964,"delay":0,"ttmEps":0,"open":37.08,"prevYearClose":35.8964,"prevWeekClose":36.5894,"prevMonthClose":38.1173,"prevQuarterClose":36.0159,"fiveDayClose":36.5894,"twentyDayClose":38.7469,"sixtyDayClose":35.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGNG\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"AGNG","amount":0.155552,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"AGNG","amount":0.172198,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"date":"2025-06-27","symbol":"AGNG","amount":0.14218,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"date":"2024-12-30","symbol":"AGNG","amount":0.14617,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-07","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-07"},{"date":"2024-06-27","symbol":"AGNG","amount":0.10429,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-07-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGNG\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-06","value":0.161273,"currency":"USD"},{"executeDate":"2021-06-29","recordDate":"2021-06-30","paymentDate":"2021-07-08","value":0.034042,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.174268,"currency":"USD"},{"executeDate":"2022-06-29","recordDate":"2022-06-30","paymentDate":"2022-07-08","value":0.107236,"currency":"USD"},{"executeDate":"2022-12-29","recordDate":"2022-12-30","paymentDate":"2023-01-09","value":0.021742,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGNG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGNG\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","IHE","LU2746668974.SGD","MEDI","JDOC","LU1551013425.SGD","TBXU","MEDX","BK4588","BIB","NAMS","LU0096364046.USD","IYH","IBB","PJP","LU2491049909.HKD","MHIP","SLN","PPH","HRTS","IXJ","LLY","TRUH","OZEM","VHT","CURE","LLYX","TMED","LLII","CANC","IBBQ","LU1988902786.USD","FTXH","ELIS","FHLC","AGNG","BK4581","LU0456855351.SGD","ELIL","GDOC","PBE","AMGN","LU2324357040.USD","LLYZ","BBH","THNR","WDNA","RXL","ILDR","IE00BK4W5L77.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665945893","title":"麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航","url":"https://stock-news.laohu8.com/highlight/detail?id=2665945893","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665945893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:10","pubTimestamp":1788761405,"startTime":"0","endTime":"0","summary":"麦科田通过多赛道布局、全球化运营、持续并购整合，构建一个抗周期、可持续的医疗器械平台。","market":"fut","thumbnail":"https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6537932","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","HEXmain","IEIH","MEDX","RSPH","LNGR","PTH","HART","02041","09996","159883","LGHT","MDEV","BK1100","AGNG","BK1583","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399937","title":"山東省寧陽縣市場監管局開展醫療器械專項現場檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399937","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399937?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:37","pubTimestamp":1788755820,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 9月7日，山东省宁阳县市场监管局执法人员深入辖区零售药店，开展医疗器械专项现场检查。执法人员重点查看血压计等二类医疗器械，仔细核对产品注册资料、进货票据，查验产品有效期、包装标识，排查有无过期失效、来路不明产品等风险隐患。检查过程坚持监管和指导同步开展，现场向药店从业人员讲解医疗器械经营相关规定，指出经营中的不足，督促经营者落实主体责任，规范进货查验和日常自查工作。下一步，该局将持续加大医疗器械监管频次，紧盯零售药店经营风险，切实保障群众用械安全。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-07/doc-iniqykzy9680694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1100","09996","159883","MDEV","PTH","IEIH","HART","BK1574","GDOC","RSPH","LGHT","BK1583","MEDX","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399350","title":"又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399350?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:07","pubTimestamp":1788754034,"startTime":"0","endTime":"0","summary":"随着多家医疗器械企业中报密集披露，医疗器械板块整体修复态势明确，业绩端已出现向上拐点。9月7日，麦科田正式于港交所挂牌上市，这意味着港股医疗器械板块再添一家平台型龙头。据多家权威机构测算，2026年全球医疗器械市场规模预计在6000亿至8000亿美元之间，并有望于2035年突破万亿美元大关。整体来看，麦科田此次登陆港股，业绩方面盈利拐点已经确认，商业化路径成熟，平台型的全面产品组合和全","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","RSPH","BK4585","LNGR","KCAI","IEIH","02041","BK4588","BK1100","159883","09996","BK1574","HART","MEDX","GDOC","VXUS","PTH","LGHT","AGNG","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665962333","title":"從美妝到生物科技公司 植物醫生挺進大健康領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2665962333","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665962333?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:46","pubTimestamp":1788752760,"startTime":"0","endTime":"0","summary":"渠道红利退去、流量成本攀升、产品同质化加剧……中国美妆行业正经历从“快车道”到“窄门”的残酷转型。当“一招鲜”的战术红利消失，建立底层技术壁垒不再是可选项，而是生存项。当全行业 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["GDOC","IBBJ","IEIH","XBI","BK4581","BK4588","LNGR","MEDX","AGNG","SYNB","BK4585","159837","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LGHT","BK1583","HART","BK1100","BK4127","LNGR","IEIH","KCE","REDS","MEDX","09996","FRHC","PTH","AGNG","159883","RSPH","IPOS","MDEV","GDOC","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665250366","title":"海南出台醫療器械委託生產監管新政","url":"https://stock-news.laohu8.com/highlight/detail?id=2665250366","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665250366?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 07:43","pubTimestamp":1788651815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","HART","LNGR","MDEV","PTH","GDOC","RSPH","LGHT","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665350040","title":"格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2665350040","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665350040?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 14:01","pubTimestamp":1788588060,"startTime":"0","endTime":"0","summary":"格式塔创始人、CEO彭雷表示，脑机接口赛道要解决的核心问题就一个：持续提高对脑内读写的分辨率。在他看来，至少在看得见的三到五年内，脑机接口本质上还是严肃的医疗器械，它的创新落地，付费方一定是医疗体系与患者。他指出，如何依托我国特色的医疗保障体系，让前沿的脑机接口应用纳入医保，惠及更多患者、解决实际病痛，这就是付费层面需要思考的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccw0443893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","GDOC","09996","HART","IBRN","LNGR","RSPH","AGNG","IEIH","PTH","LGHT","159883","BK1583","MDEV","MNTL","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665561483","title":"研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方","url":"https://stock-news.laohu8.com/highlight/detail?id=2665561483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665561483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 02:45","pubTimestamp":1788547556,"startTime":"0","endTime":"0","summary":"研究发现，美国越来越多的12岁以下儿童被开具减肥药处方路透9月4日-据周五发表的一项研究显示，由于医生们正在为患有肥胖症的年轻患者寻求新的有效治疗方法，自2019年以来，美国12岁以下儿童的GLP-1减肥药处方量已增长了300多倍。该研究涵盖了350多万名8至11岁、患有肥胖症但未患糖尿病的儿童，结果显示GLP-1减肥药的处方率从2019年的0.03%上升至截至6月的9.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4T44W18V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU1548497426.USD","LU1623119135.USD","PJP","LU2237443382.USD","LU1691799644.USD","LU2456880835.USD","LU0203202063.USD","LU1323610961.USD","BK4588","IE0009355771.USD","LU0096364046.USD","AGNG","LU1551013425.SGD","IE0005OL40V9.USD","LU0823416689.USD","LU2552382215.SGD","LU2237443895.HKD","LU2028103732.USD","LU2023250330.USD","LU2756315318.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU2213496289.HKD","LU0689472784.USD","LLII","IE00BZ1G4Q59.USD","CANC","LU0061475181.USD","LU1145028129.USD","LU2461242641.AUD","LU2491049909.HKD","IE0004445015.USD","IE00BJJMRX11.SGD","LU0471298694.HKD","LU0345770993.USD","LU0210536198.USD","LU0266013472.USD","LU2237443978.SGD","NVOX","LU2324357040.USD","CURE","IE0001KFT4U8.USD","BK4532","LU0820561909.HKD","IE00BJJMRZ35.SGD","LU2491050071.SGD","LU1917777945.USD","PPH","LU2491050154.USD","LU0345770308.USD","LU0882574139.USD","LU1551013342.USD","LU2750360997.AUD","SGXZ99366536.SGD","LU0683600562.USD","GDOC","LU1267930730.SGD","LU1804176565.USD","LU2471134879.HKD","SG9999013999.USD","LU0323591593.USD","LU1232071149.USD","IE00BKVL7J92.USD","LU1093756168.USD","LU2237443465.HKD","LU1720051017.SGD","HRTS","LU1280957306.USD","LU1035775433.USD","NVOC","IE00B1BXHZ80.USD","LLYZ","TRUH","LU1868836757.USD","LU2756315664.SGD","IE00BK4W5L77.USD","LU1868836591.USD","LU2108987350.USD","LU2087625088.SGD","LU2168564495.EUR","BK4516","SG9999018865.SGD","BK4007","LU0882574055.USD","IE00BFSS8Q28.SGD","LU0889565916.HKD","LU1720051108.HKD","GB00BDT5M118.USD","FTXH","LU1069344957.HKD","LU1868837136.USD","LU2462591350.SGD","LU0964807845.USD","LU2552382058.USD","IE00BKPKM429.USD","LU2468319806.SGD","LU0316494557.USD","SG9999001176.SGD","SG9999015986.USD","NVO","LU0079474960.USD","LU2360106947.USD","MHIP","SG9999018857.SGD","LU2168563687.JPY","SG9999015952.SGD","LU0256863811.USD","THNR","LU2168564222.USD","XLV","LU0122379950.USD","LU1629891620.HKD","ELIS","IE0004445239.USD","LU2750360641.GBP","LU0097036916.USD","LU0354030438.USD","IE00B2B36J28.USD","LU1366192091.USD","BK4581","LU1061106388.HKD","LU2237438978.USD","LU0456855351.SGD","LU2271345857.HKD","SG9999014906.USD","LU2417539215.USD","LU0943347566.SGD","IE00BKDWB100.SGD","LU0820562030.AUD","LU2089284900.SGD","LU0320765992.SGD","LU2106854487.HKD","LU2552382132.HKD","LU0006306889.USD","LU2236285917.USD","LU0225283273.USD","LU0058720904.USD","LU2361045086.USD","LU2896262040.SGD","LU2237443622.USD","LU0417517546.SGD","LU0786609619.USD","IE00B4JS1V06.HKD","LU2746668974.SGD","LU1989771016.USD","LU0820561818.USD","LU0106261372.USD","LU0432979614.USD","LU2746668461.USD","LU1868837300.USD","LU0094547139.USD","LLY","LU0640476718.USD","IHE","LU0385154629.USD","BK4599","LU1712237335.SGD","LU2211815571.USD","LU0466842654.USD","BK4533","LU0133085943.USD","LU1814569148.SGD","OZEM","LU0198837287.USD","IE00B1XK9C88.USD","IE00BWXC8680.SGD","LU0823434583.USD","ILDR","IXJ","LU1064131342.USD","LU2357305700.SGD","LU2471134523.USD","LU0154236417.USD","SG9999001176.USD","SG9999014898.SGD","SGXZ57979304.SGD","WDNA","LU0234572021.USD","MEDX","LU0320765059.SGD","LU2168564149.EUR","LU2361044949.HKD","RXL","LU0708995401.HKD","IE0002141913.USD","LU1291159041.SGD","LU1023059063.AUD","MEDI","IE00BJLML261.HKD","LU0174119429.USD","IE00BJT1NW94.SGD","LU2237443549.SGD","LU0353189680.USD","LU0787776722.HKD","LU0353189763.USD","LU1057294990.SGD","IE00BJJMRY28.SGD","SGXZ51526630.SGD","NVOH","IE00B775H168.HKD","SG9999014880.SGD","SG9999015978.USD","LU0158827948.USD","LU0203201768.USD","LU0354030511.USD","LU1127390331.HKD","LU2462157665.USD","SGXZ31699556.SGD","SG9999017495.SGD","LU1868836914.USD","IYH","LU2112291526.USD","LU2089984988.USD","VHT","LU2023251221.USD","LU0471298777.SGD","LU1988902786.USD","LU2471134952.CNY","LU2602419157.SGD","BK4585","ELIL","IE00B7KXQ091.USD","LU1093756325.SGD","JDOC","IE00BFSS7M15.SGD","SG9999014914.USD","FHLC","BK4534","LU0109391861.USD","LU0672654240.SGD","LLYX","LU0823434740.USD","SG9999015945.SGD","LU2111349929.HKD","IE00BK4W5M84.HKD","LU0238689110.USD","LU2063271972.USD","LU2089283258.USD","IE00B4R5TH58.HKD","LU2023250504.SGD","TMED","LU0158827781.USD","LU0109394709.USD","LU1983299246.USD","IE00BN29S564.USD","LU0256863902.USD","LU2361044865.SGD","LU2168564065.EUR","LU2264538146.SGD","LU2265009873.SGD","LU2471134796.USD","LU1974910355.USD","SGXZ81514606.USD","LU1979441026.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664633992","title":"服務退役軍人有成效，貴州企業獲國家級授牌！","url":"https://stock-news.laohu8.com/highlight/detail?id=2664633992","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664633992?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 19:20","pubTimestamp":1788520800,"startTime":"0","endTime":"0","summary":"9月3日，中国退役军人就业创业服务促进会授牌仪式在贵阳举行。贵州省松平生物科技有限公司被授予“中国退役军人就业创业服务促进会副理事长单位”会员。据了解，贵州省松平生物科技有限公司为退役军人创办，主业聚焦生物制药、健康保健和职业培训。此次授牌，标志着该企业正式纳入全国退役军人就业创业服务体系，将获得促进会在资源对接、政策指导、人才培育、创业帮扶等多方面的专业支持，让企业能更好地帮助退役军人就业创业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-04/doc-iniqskuq0832283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HBImain","LNGR","SYNB","IBBJ","MEDX","XBI","BK4585","IEIH","BK4581","AGNG","BK4588","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664233645","title":"聯邦制藥(03933.HK)：UBT251注射液完成中國超重/肥胖III期臨床研究首例試驗參與者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664233645","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664233645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 18:55","pubTimestamp":1788519354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","SYNB","IEIH","AGNG","LNGR","IBBJ","GDOC","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381419","title":"里昂：生物科技行業基本面仍穩固，首選百濟神州、信達生物及維立志博","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381419","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381419?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 14:16","pubTimestamp":1788502604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","BK4588","GDOC","LNGR","SYNB","XBI","BK4139","BK4585","MEDX","BK4526","IEIH","ONC","IBBJ","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381446","title":"從護膚到大健康，植物醫生想成為一家生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381446","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381446?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 12:39","pubTimestamp":1788496793,"startTime":"0","endTime":"0","summary":"从高山植物护肤，到中国原创成分，再到大健康产品，它正在尝试把高山植物科研从服务于单一护肤品的研发能力，变成一套能够跨品类持续产生价值的科研底座。这个问题的答案，将决定植物医生最终是增加了一条大健康产品线，还是能够真正完成从护肤品牌向生物科技公司的能力跃迁。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788496062591431273","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IBBJ","SYNB","BK4588","BK4581","159837","MEDX","AGNG","IEIH","LNGR","XBI","GDOC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664959385","title":"我國長期護理保險參保人數超3.2億","url":"https://stock-news.laohu8.com/highlight/detail?id=2664959385","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664959385?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:46","pubTimestamp":1788489982,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据新华社报道，国家医保局副局长王文君4日在国新办举行的“开局起步‘十五五’”系列主题新闻发布会上介绍，我国长期护理保险参保人数超3.2亿，基金累计支出1142亿元，为超过460万失能人员提供了护理服务。截至目前，22个省份印发省级实施方案，建制统筹地区达到121个，预计今年底全国将拓展至247个统筹地区。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990674","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383767","title":"我國長期護理保險參保人數超3.2億","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383767?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:28","pubTimestamp":1788488907,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383756","title":"我國長期護理保險參保人數超3.2億","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383756","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383756?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:28","pubTimestamp":1788488884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388058","title":"109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["JDOC","LU0820561909.HKD","LU1236620834.HKD","LU1267930490.SGD","PPH","XLV","LU2433249047.HKD","XMMO","SBIO","LU0124676726.USD","LU1496350502.SGD","BK4533","LU0114720955.EUR","LU1551013425.SGD","LU0859254822.USD","TRUH","FHLC","PJP","KCE","FTXH","LU2089984988.USD","LU2129689605.HKD","GLAM","LU2125909593.SGD","IXJ","IE000WAW04H5.SGD","ABBV","CALF","APGE","LU0069063385.USD","LU0170899867.USD","LU2087621335.USD","IYH","LU0203345920.USD","MEDX","LU1839511570.USD","LU2237443549.SGD","MYLD","LU0234570918.USD","LU0320765646.SGD","AGNG","LU0128525929.USD","LU2129689514.USD","LU2237443895.HKD","RXL","IE00B19Z3B42.SGD","VHT","SG9999003800.SGD","LU0310800379.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664053388","title":"109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664053388","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664053388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维于周四表示，公司已完成对抗炎药物研发商 Apogee Therapeutics价值 109 亿美元的收购。笔交易是这家制药巨头自 2019 年以来规模最大的补强型收购，智通财经AAPP于今年 6 月首次对此进行了报道。艾伯维预计，该项收购将对其调整后稀释每股收益产生负面影响，其中 2026 年将减少 0.14 美元，2027 年减少约 0.46 美元，并预计将于 2032 年开始实现增益。该指引已包含与完成 Apogee 收购相关的每股 0.14 美元稀释效应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1037948541.HKD","IE0002270589.USD","LU0057025933.USD","LU0203345920.USD","VHT","MYLD","LU1989772840.SGD","TRUH","BK4566","SG9999011175.SGD","BK4581","XLV","IYH","LU2237443549.SGD","LU1983299246.USD","LU0124676726.USD","LU0256863902.USD","LU0965509283.SGD","FHLC","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","AGNG","LU0985320562.USD","LU1003077747.HKD","IE00B19Z3581.USD","LU1718418525.SGD","IE00B2B36J28.USD","XMMO","JDOC","SBIO","MEDX","PPH","LU1934455194.USD","LU0170899867.USD","LU1236620834.HKD","BK4559","GLAM","IXJ","LU2089283258.USD","IE0004445239.USD","KCE","PJP","IE00BLSP4239.USD","CALF","FTXH","RXL","LU0289739343.SGD","ABBV","LU1093756168.USD","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112455320","title":"艾伯維公布Cervino三期試驗積極頂線結果：Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1112455320","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112455320?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:19","pubTimestamp":1788441558,"startTime":"0","endTime":"0","summary":"艾伯维公司今日宣布，其针对复发或难治性多发性骨髓瘤患者的关键性Cervino三期临床试验，取得了积极的顶线数据。研究结果显示，在研药物Etentamig不仅显著提高了患者的客观缓解率，更在延长无进展生存期方面展现出压倒性的统计学优势。Cervino试验是一项全球性的、随机、开放标签的注册研究，旨在评估Etentamig相较于标准治疗的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000WAW04H5.SGD","LU2112291526.USD","LU1057294990.SGD","LU0158827948.USD","LU1989772840.SGD","IE00BFTCPJ56.SGD","LU1934455863.HKD","LU2468319806.SGD","XLV","LU1037948541.HKD","IE0004445239.USD","LU0553294199.USD","LU1061106388.HKD","LU1267930490.SGD","LU1244550221.USD","LU0868494617.USD","LU1551013342.USD","LU0511384066.AUD","LU0203345920.USD","LU1983299246.USD","IE000BZT7R73.USD","IE00B4R5TH58.HKD","LU0289739343.SGD","LU0472753341.HKD","LU0256863902.USD","BK4550","LU0689472784.USD","LU1236620750.USD","LU0708994859.HKD","LU0057025933.USD","LU0545039389.USD","IE00B2B36J28.USD","LU0310800379.SGD","LU0823416689.USD","LU1923622614.USD","IE000F7OJYX1.SGD","LU0256863811.USD","LU0432979614.USD","GLAM","LU1093756168.USD","SG9999011175.SGD","LU2237443895.HKD","IE0009355771.USD","LU0124676726.USD","LU0820561818.USD","LU1989771016.USD","LU0456855351.SGD","LU1003077747.HKD","LU0203347892.USD","LU2237443978.SGD","PPH","LU0114720955.EUR","LU0098860793.USD","IE000MB6IJN5.SGD","LU2237443465.HKD","LU0861579265.USD","BK4534","LU0170899867.USD","IE00BSNM7G36.USD","LU0289961442.SGD","BK4139","LU0689626769.HKD","LU2125909247.SGD","LU2347655073.USD","IXJ","IE0002141913.USD","FTXH","LU0943347566.SGD","BK4581","IE00B3PB1722.GBP","IE00BBT3K403.USD","LU2129689514.USD","LU2133065610.SGD","LU0985320562.USD","IE00B19Z3B42.SGD","IYH","LU1585245621.USD","IE00BLSP4452.SGD","LU0289739699.SGD","LU1244550577.SGD","BK4566","LU0726765562.USD","RXL","IE00BVYPNW00.USD","LU2237443382.USD","LU0320765646.SGD","LU0859254822.USD","SG9999015986.USD","LU0029864427.USD","LU0912757837.SGD","LU0234572021.USD","LU0395794307.EUR","LU2357627491.SGD","SG9999015978.USD","LU1037948897.HKD","VHT","SG9999015952.SGD","FHLC","LU0795875086.SGD","IE00B19Z3581.USD","LU1718418525.SGD","LU0198837287.USD","LU0417517546.SGD","LU0069063385.USD","IE00BGHQF631.EUR","LU1023059063.AUD","LU1236620834.HKD","LU1670627923.USD","LU0868494708.USD","LU0882574055.USD","LU0122379950.USD","LU0965509283.SGD","SG9999003800.SGD","LU2089283258.USD","LU2125909593.SGD","LU0128525929.USD","LU2129689431.USD","LU2433249047.HKD","IE0000B7K699.USD","SG9999015945.SGD","LU0942090050.USD","LU0965508806.USD","LU2237443622.USD","LU1989772923.USD","LU2089984988.USD","LU1732799900.SGD","LU0234570918.USD","LU0738911758.USD","LU0949170772.SGD","LU2237443549.SGD","SG9999001440.SGD","BK4559","JDOC","IE00B42XCP33.USD","LU1162221912.USD","MEDX","LU1267930573.SGD","BK4533","LU0965509010.AUD","LU1244550494.USD","IE000SO60NU8.SGD","LU1839511570.USD","LU2023251221.USD","LU0661504455.SGD","LU1934455194.USD","LU0211327993.USD","LU2129689605.HKD","LU1732800096.USD","IE00BN8TJ469.HKD","ABBV","IE00BLSP4239.USD","LU0211328371.USD","LU1430594728.SGD","LU1934455277.USD","LU0795875169.SGD","AGNG","LU1670628061.USD","TRUH","IE00BJJMRZ35.SGD","LU0965509101.SGD","LU1929549753.HKD","LU0310799852.SGD","LU1074936037.SGD","BK4588","LU1093756325.SGD","PJP","IE00BJT1NW94.SGD","LU0820561909.HKD","LU1291159041.SGD","LU2347655156.SGD","LU2089284900.SGD","IE00BVYPNV92.GBP","BK4585","IE00BDGV0183.EUR","LU1551013425.SGD","LU1496350502.SGD","LU0058720904.USD","LU1496350171.SGD","IE0002270589.USD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287786","title":"艾伯維的血液癌症藥物達到了晚期臨床試驗的目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287786","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441535,"startTime":"0","endTime":"0","summary":"艾伯维的血液癌症药物达到了晚期临床试验的目标路透9月3日-艾伯维（AbbVie）ABBV.N周四表示，其用于治疗某类血液癌症的药物已达到一项晚期临床试验的主要目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4T44V12O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","LU0128525929.USD","LU1989771016.USD","LU0511384066.AUD","SG9999011175.SGD","TRUH","FHLC","ABBV","LU1244550494.USD","LU1732800096.USD","IE00BBT3K403.USD","PJP","LU2237443382.USD","LU1430594728.SGD","IXJ","SG9999001440.SGD","LU0943347566.SGD","LU0545039389.USD","LU1934455863.HKD","SG9999003800.SGD","SG9999015945.SGD","LU0170899867.USD","XLV","LU0942090050.USD","FTXH","IE00B2B36J28.USD","LU2089283258.USD","LU2237443465.HKD","PPH","LU0456855351.SGD","LU0859254822.USD","IE000WAW04H5.SGD","LU0861579265.USD","LU1093756325.SGD","VHT","LU2125909593.SGD","LU1839511570.USD","MEDX","BK4588","LU0795875169.SGD","JDOC","AGNG","IYH","LU1934455194.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0289961442.SGD","LU1244550577.SGD","GLAM","RXL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}